ICU Medical Net Profit Margin 2010-2024 | ICUI
ICU Medical net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| ICU Medical Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $2.34B | $-0.11B | -4.70% |
| 2024-06-30 | $2.30B | $-0.07B | -3.04% |
| 2024-03-31 | $2.26B | $-0.06B | -2.61% |
| 2023-12-31 | $2.26B | $-0.03B | -1.33% |
| 2023-09-30 | $2.25B | $-0.03B | -1.29% |
| 2023-06-30 | $2.29B | $-0.05B | -2.14% |
| 2023-03-31 | $2.31B | $-0.05B | -1.99% |
| 2022-12-31 | $2.28B | $-0.07B | -3.25% |
| 2022-09-30 | $2.04B | $-0.04B | -1.86% |
| 2022-06-30 | $1.78B | $0.01B | 0.34% |
| 2022-03-31 | $1.54B | $0.04B | 2.66% |
| 2021-12-31 | $1.32B | $0.10B | 7.82% |
| 2021-09-30 | $1.30B | $0.11B | 8.41% |
| 2021-06-30 | $1.28B | $0.10B | 8.05% |
| 2021-03-31 | $1.26B | $0.09B | 7.46% |
| 2020-12-31 | $1.27B | $0.09B | 6.85% |
| 2020-09-30 | $1.27B | $0.08B | 6.47% |
| 2020-06-30 | $1.26B | $0.08B | 6.69% |
| 2020-03-31 | $1.26B | $0.09B | 6.96% |
| 2019-12-31 | $1.27B | $0.10B | 8.06% |
| 2019-09-30 | $1.29B | $0.07B | 5.74% |
| 2019-06-30 | $1.31B | $0.05B | 3.59% |
| 2019-03-31 | $1.36B | $0.06B | 4.05% |
| 2018-12-31 | $1.40B | $0.03B | 2.07% |
| 2018-09-30 | $1.43B | $0.09B | 6.02% |
| 2018-06-30 | $1.45B | $0.09B | 5.95% |
| 2018-03-31 | $1.42B | $0.02B | 1.27% |
| 2017-12-31 | $1.29B | $0.07B | 5.34% |
| 2017-09-30 | $1.02B | $0.03B | 2.85% |
| 2017-06-30 | $0.77B | $0.05B | 6.21% |
| 2017-03-31 | $0.54B | $0.10B | 18.96% |
| 2016-12-31 | $0.38B | $0.06B | 16.84% |
| 2016-09-30 | $0.37B | $0.06B | 15.78% |
| 2016-06-30 | $0.36B | $0.06B | 15.43% |
| 2016-03-31 | $0.35B | $0.05B | 15.14% |
| 2015-12-31 | $0.34B | $0.05B | 13.20% |
| 2015-09-30 | $0.33B | $0.05B | 14.20% |
| 2015-06-30 | $0.32B | $0.04B | 11.49% |
| 2015-03-31 | $0.32B | $0.03B | 9.15% |
| 2014-12-31 | $0.31B | $0.03B | 8.41% |
| 2014-09-30 | $0.31B | $0.03B | 10.42% |
| 2014-06-30 | $0.31B | $0.04B | 11.82% |
| 2014-03-31 | $0.31B | $0.04B | 12.14% |
| 2013-12-31 | $0.31B | $0.04B | 12.74% |
| 2013-09-30 | $0.32B | $0.04B | 12.23% |
| 2013-06-30 | $0.32B | $0.04B | 12.62% |
| 2013-03-31 | $0.32B | $0.04B | 13.33% |
| 2012-12-31 | $0.32B | $0.04B | 12.93% |
| 2012-09-30 | $0.31B | $0.05B | 15.16% |
| 2012-06-30 | $0.31B | $0.04B | 14.43% |
| 2012-03-31 | $0.31B | $0.04B | 14.38% |
| 2011-12-31 | $0.30B | $0.04B | 14.62% |
| 2011-09-30 | $0.30B | $0.04B | 11.71% |
| 2011-06-30 | $0.30B | $0.04B | 11.71% |
| 2011-03-31 | $0.29B | $0.03B | 11.72% |
| 2010-12-31 | $0.28B | $0.03B | 10.60% |
| 2010-09-30 | $0.28B | $0.03B | 9.78% |
| 2010-06-30 | $0.25B | $0.02B | 9.45% |
| 2010-03-31 | $0.24B | $0.02B | 9.24% |
| 2009-12-31 | $0.23B | $0.03B | 10.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.751B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |